Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Gottwein

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Hepatology (Baltimore, Md.)|September 3, 2022
Identification of novel neutralizing determinants for protection against HCVGarazi P Alzua, Anne F Pihl, Anna Offersgaard, et al.
Emerging Microbes & Infections|October 15, 2025
SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspotsYuyong Zhou, Karen A Gammeltoft, Helena D Tjørnelund-Sjursen, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral ReplicationSantseharay Ramirez, Carlota Fernandez-Antunez, Andrea Galli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2025
Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoproteinLaura Radić, Anna Offersgaard, Tereza Kadavá, et al.
Nature|July 5, 2023
Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotideAnna V Sherwood, Lizandro R Rivera-Rangel, Line A Ryberg, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Hepatology (Baltimore, Md.)|September 3, 2022
Identification of novel neutralizing determinants for protection against HCVGarazi P Alzua, Anne F Pihl, Anna Offersgaard, et al.
Emerging Microbes & Infections|October 15, 2025
SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspotsYuyong Zhou, Karen A Gammeltoft, Helena D Tjørnelund-Sjursen, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral ReplicationSantseharay Ramirez, Carlota Fernandez-Antunez, Andrea Galli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2025
Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoproteinLaura Radić, Anna Offersgaard, Tereza Kadavá, et al.
Nature|July 5, 2023
Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotideAnna V Sherwood, Lizandro R Rivera-Rangel, Line A Ryberg, et al.
Pageof 6